000650 仁和药业
交易中 06-22 14:27:51
资讯
新帖
简况
每周股票复盘：仁和药业（000650）实控人变更为杨潇，奥司他韦获批
证券之星 · 06-21 02:23
每周股票复盘：仁和药业（000650）实控人变更为杨潇，奥司他韦获批
仁和药业（000650）披露子公司获得磷酸奥司他韦干混悬剂药品注册证书，6月16日股价下跌1.31%
证券之星 · 06-16
仁和药业（000650）披露子公司获得磷酸奥司他韦干混悬剂药品注册证书，6月16日股价下跌1.31%
仁和药业：已获批件的产品公司都有生产和销售
证券之星 · 06-16
仁和药业：已获批件的产品公司都有生产和销售
股市必读：仁和药业（000650）6月15日董秘有最新回复
证券之星 · 06-16
股市必读：仁和药业（000650）6月15日董秘有最新回复
仁和药业：截至2026年5月29日，大约9.02万户左右
证券之星 · 06-12
仁和药业：截至2026年5月29日，大约9.02万户左右
仁和药业：截止2026年5月31号，公司的员工人数4805人
证券之星 · 06-10
仁和药业：截止2026年5月31号，公司的员工人数4805人
仁和药业：深圳三浦公司还需在原料、精准功效、技术壁垒和产品差异化等方面下苦功
证券之星 · 06-09
仁和药业：深圳三浦公司还需在原料、精准功效、技术壁垒和产品差异化等方面下苦功
仁和药业（000650）披露股份回购进展公告，6月1日股价上涨1.5%
证券之星 · 06-01
仁和药业（000650）披露股份回购进展公告，6月1日股价上涨1.5%
股市必读：仁和药业（000650）5月25日董秘有最新回复
证券之星 · 05-26
股市必读：仁和药业（000650）5月25日董秘有最新回复
仁和药业：2026年回购股份已达14,000,650股
证券之星 · 05-25
仁和药业：2026年回购股份已达14,000,650股
仁和药业：2026年回购股份已达14,000,650股
证券之星 · 05-25
仁和药业：2026年回购股份已达14,000,650股
仁和药业：截至2025年12月31日产生收益145.36万
证券之星 · 05-25
仁和药业：截至2025年12月31日产生收益145.36万
股市必读：仁和药业（000650）5月20日董秘有最新回复
证券之星 · 05-21
股市必读：仁和药业（000650）5月20日董秘有最新回复
仁和药业：公司与控股股东仁和集团在人员、资产、财务、机构和业务方面都是独立的
证券之星 · 05-20
仁和药业：公司与控股股东仁和集团在人员、资产、财务、机构和业务方面都是独立的
股市必读：仁和药业（000650）5月18日董秘有最新回复
证券之星 · 05-19
股市必读：仁和药业（000650）5月18日董秘有最新回复
仁和药业：目前公司有减肥药品的销售
证券之星 · 05-18
仁和药业：目前公司有减肥药品的销售
仁和药业：股东会审议通过后两个月内完成分红派息
证券之星 · 05-18
仁和药业：股东会审议通过后两个月内完成分红派息
仁和药业（000650）披露回购公司股份比例达到1%暨回购进展的公告，5月13日股价下跌0.35%
证券之星 · 05-13
仁和药业（000650）披露回购公司股份比例达到1%暨回购进展的公告，5月13日股价下跌0.35%
仁和药业：产品质量始终是品牌的立业之本
证券之星 · 05-13
仁和药业：产品质量始终是品牌的立业之本
股市必读：仁和药业（000650）5月8日披露最新机构调研信息
证券之星 · 05-11
股市必读：仁和药业（000650）5月8日披露最新机构调研信息
加载更多
公司概况
公司名称：
仁和药业股份有限公司
所属行业：
医药制造业
上市日期：
1996-12-10
主营业务：
仁和药业股份有限公司的主营业务是药品及大健康产品的生产和销售。公司的主要产品是口服固体制剂、口服液体制剂、大容量注射剂、小容量注射剂、外用洗剂、搽剂、栓剂、软膏剂、健康相关产品。
发行价格：
6.26
{"stockData":{"symbol":"000650","market":"SZ","secType":"STK","nameCN":"仁和药业","latestPrice":5.16,"timestamp":1782109671000,"preClose":5.13,"halted":0,"volume":14256045,"delay":0,"changeRate":0.0058,"floatShares":1331000000,"shares":1400000000,"eps":0.2638,"marketStatus":"交易中","change":0.03,"latestTime":"06-22 14:27:51","open":5.14,"high":5.23,"low":5.01,"amount":72406000,"amplitude":0.0429,"askPrice":5.16,"askSize":217,"bidPrice":5.15,"bidSize":292,"shortable":0,"etf":0,"ttmEps":0.2638,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1782111600000},"marketStatusCode":2,"adr":0,"adjPreClose":5.13,"symbolType":"stock","openAndCloseTimeList":[[1782091800000,1782099000000],[1782104400000,1782111600000]],"highLimit":5.64,"lowLimit":4.62,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1399938234,"isCdr":false,"pbRate":1.11,"roa":"--","peRate":19.560273,"roe":"2.2%","epsLYR":0.28,"committee":-0.192521,"marketValue":7224000000,"turnoverRate":0.0107,"status":0,"floatMarketCap":6870000000},"requestUrl":"/m/hq/s/000650","defaultTab":"news","newsList":[{"id":"2645095783","title":"每周股票复盘：仁和药业（000650）实控人变更为杨潇，奥司他韦获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2645095783","media":"证券之星","labels":["executive","productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645095783?lang=zh_cn&edition=full","pubTime":"2026-06-21 02:23","pubTimestamp":1781979789,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，仁和药业报收于5.13元，较上周的5.3元下跌3.21%。本周，仁和药业6月15日盘中最高价报5.35元。本周关注点公司公告汇总：实际控制人由杨文龙变更为杨潇，相关工商变更已完成。本次转让为间接控股股东的控制权变动，公司控股股东仍为仁和（集团）发展有限公司，实际控制人由杨文龙变更为杨潇。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062100000629.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","000650","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643756721","title":"仁和药业（000650）披露子公司获得磷酸奥司他韦干混悬剂药品注册证书，6月16日股价下跌1.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643756721","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643756721?lang=zh_cn&edition=full","pubTime":"2026-06-16 18:36","pubTimestamp":1781606162,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘，仁和药业报收于5.26元，较前一交易日下跌1.31%，最新总市值为73.64亿元。近日，仁和药业子公司江西药都仁和制药有限公司收到国家药品监督管理局核准签发的磷酸奥司他韦干混悬剂《药品注册证书》，药品批准文号为国药准字H20264737，剂型为口服混悬剂，注册分类为化学药品3类。该药品适用于成人和2周龄及以上儿童的甲型与乙型流感治疗，以及1岁及以上人群的流感预防。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600035305.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0097","000650","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643731297","title":"仁和药业：已获批件的产品公司都有生产和销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2643731297","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643731297?lang=zh_cn&edition=full","pubTime":"2026-06-16 15:06","pubTimestamp":1781593580,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)06月16日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！贵公司年报披露有35款新药取得批文，请问截止2026年5月31日，这35款新药中有几款上市销售？仁和药业回复：尊敬的投资者您好，公司2025年年度报告全文在研发投入部分披露了44个药品研发名称及进展情况等，截止今天，公司药品通过一致性评价和已获取药品注册证书的有17个。已获批件的产品，除了昨天刚刚披露的磷酸奥司他韦干混悬剂，其他已获批件的产品，公司都有生产和销售。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600020826.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0239","000650","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643578855","title":"股市必读：仁和药业（000650）6月15日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2643578855","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643578855?lang=zh_cn&edition=full","pubTime":"2026-06-16 02:23","pubTimestamp":1781547790,"startTime":"0","endTime":"0","summary":"截至2026年6月15日收盘，仁和药业报收于5.33元，上涨0.57%，换手率0.95%，成交量12.62万手，成交额6700.63万元。关于实际控制人股权完成工商变更登记的公告2026年6月15日，仁和药业收到仁和（集团）发展有限公司通知，杨文龙先生向其子杨潇先生转让所持仁和（集团）发展有限公司73.1137%股权的工商变更登记手续已办理完毕。本次变更后，公司控股股东仍为仁和（集团）发展有限公司，实际控制人由杨文龙变更为杨潇。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600001730.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0097","000650","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642259737","title":"仁和药业：截至2026年5月29日，大约9.02万户左右","url":"https://stock-news.laohu8.com/highlight/detail?id=2642259737","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642259737?lang=zh_cn&edition=full","pubTime":"2026-06-12 11:36","pubTimestamp":1781235401,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)06月11日在投资者关系平台上答复投资者关心的问题。投资者提问：你好！请问贵公司26年5月31日为止，股东人数为多少？谢谢！仁和药业回复：谢谢您的关注，截至2026年5月29日，大约9.02万户左右。具体数据，根据相关法规，请您先向公司证券部提交股东身份证明，谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061200014722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0097","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642461194","title":"仁和药业：截止2026年5月31号，公司的员工人数4805人","url":"https://stock-news.laohu8.com/highlight/detail?id=2642461194","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642461194?lang=zh_cn&edition=full","pubTime":"2026-06-10 16:03","pubTimestamp":1781078590,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)06月10日在投资者关系平台上答复投资者关心的问题。投资者提问：你好！请问，截止26年5月31号公司的员工人数是多少？不是股东人数！谢谢。仁和药业回复：尊敬的投资者您好，截止2026年5月31号，公司的员工人数4805人。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061000026218.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0097","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642145986","title":"仁和药业：深圳三浦公司还需在原料、精准功效、技术壁垒和产品差异化等方面下苦功","url":"https://stock-news.laohu8.com/highlight/detail?id=2642145986","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642145986?lang=zh_cn&edition=full","pubTime":"2026-06-09 11:34","pubTimestamp":1780976080,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业06月09日在投资者关系平台上答复投资者关心的问题。受中国境内化妆品行业需求消费理性化、供给端监管政策及竞争同质化等因素影响，近年行业整体呈现增速明显放缓、结构分化、利润受压等特征。未来深圳三浦公司还需在原料、精准功效、技术壁垒和产品差异化等方面下苦功，强化研发。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900015152.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0188","BK0239","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640950621","title":"仁和药业（000650）披露股份回购进展公告，6月1日股价上涨1.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640950621","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640950621?lang=zh_cn&edition=full","pubTime":"2026-06-01 22:24","pubTimestamp":1780323862,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，仁和药业报收于5.43元，较前一交易日上涨1.5%，最新总市值为76.02亿元。该股当日开盘5.37元，最高5.44元，最低5.31元，成交额达7880.15万元，换手率为1.1%。近日，仁和药业发布《关于股份回购进展情况的公告》。截至2026年5月31日，公司已累计回购股份16,360,050股，占公司总股本的1.1686%，最高成交价为5.73元/股，最低成交价为5.26元/股，支付总金额92,958,266.77元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100041095.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0097","BK0239","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638552380","title":"股市必读：仁和药业（000650）5月25日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2638552380","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638552380?lang=zh_cn&edition=full","pubTime":"2026-05-26 02:49","pubTimestamp":1779734949,"startTime":"0","endTime":"0","summary":"截至2026年5月25日收盘，仁和药业报收于5.41元，上涨0.56%，换手率0.7%，成交量9.36万手，成交额5052.91万元。投资者： 你好，公司已经回购了多少股份董秘： 尊敬的投资者您好，公司于2026年5月13日披露，2026年回购股份已达14,000,650股。公司在2025年3月4日和12月1日，分别使用1000万进入公司证券账户，截至2025年12月31日，产生收益145.36万。依据公司2025年度审计报告，公司处置交易性金融资产取得的投资收益为156.9571万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052600001881.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","000650","BK0239","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638558478","title":"仁和药业：2026年回购股份已达14,000,650股","url":"https://stock-news.laohu8.com/highlight/detail?id=2638558478","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638558478?lang=zh_cn&edition=full","pubTime":"2026-05-25 20:51","pubTimestamp":1779713472,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)05月25日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，公司已经回购了多少股份仁和药业回复：尊敬的投资者您好，公司于2026年5月13日披露，2026年回购股份已达14,000,650股。六月初，公司会根据规定披露回购进展公告，届时请查阅相关公告。谢谢！以上内容为证券之星据公开信息整理，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500031794.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0097","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638558493","title":"仁和药业：2026年回购股份已达14,000,650股","url":"https://stock-news.laohu8.com/highlight/detail?id=2638558493","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638558493?lang=zh_cn&edition=full","pubTime":"2026-05-25 20:51","pubTimestamp":1779713470,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)05月25日在投资者关系平台上答复投资者关心的问题。投资者提问：今天为止，公司回购了多少股份仁和药业回复：尊敬的投资者您好，公司于2026年5月13日披露，2026年回购股份已达14,000,650股。六月初，公司会根据规定披露回购进展公告，届时请查阅相关公告。谢谢！以上内容为证券之星据公开信息整理，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500031792.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0188","BK0239","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638538720","title":"仁和药业：截至2025年12月31日产生收益145.36万","url":"https://stock-news.laohu8.com/highlight/detail?id=2638538720","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638538720?lang=zh_cn&edition=full","pubTime":"2026-05-25 15:15","pubTimestamp":1779693337,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)05月25日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，近期看到相关公众号报道公司去年有超6000万元闲置资金用于炒股，但仅实现约66万元左右的收益，该情况是否属实？仁和药业回复：尊敬的投资者您好，情况不属实。公司在2025年3月4日和12月1日，分别使用1000万进入公司证券账户，截至2025年12月31日，产生收益145.36万。依据公司2025年度审计报告，公司处置交易性金融资产取得的投资收益为156.9571万元。详细见公司2025年度审计报告第93页之注释47 投资收益。以上内容为证券之星据公开信息整理，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500014999.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0239","BK0188","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637873577","title":"股市必读：仁和药业（000650）5月20日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2637873577","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637873577?lang=zh_cn&edition=full","pubTime":"2026-05-21 04:23","pubTimestamp":1779308589,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘，仁和药业报收于5.48元，下跌1.62%，换手率0.78%，成交量10.34万手，成交额5671.29万元。贵司更以“仁和集团的问题请您致电仁和集团”为由推诿。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100005037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0239","BK0188","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636924798","title":"仁和药业：公司与控股股东仁和集团在人员、资产、财务、机构和业务方面都是独立的","url":"https://stock-news.laohu8.com/highlight/detail?id=2636924798","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636924798?lang=zh_cn&edition=full","pubTime":"2026-05-20 11:36","pubTimestamp":1779248184,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业05月20日在投资者关系平台上答复投资者关心的问题。贵司更以“仁和集团的问题请您致电仁和集团”为由推诿。您的问题，仁和药业股份有限公司的证券部已向公司董事会反馈。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000019079.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650","BK0239","BK0188","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636003858","title":"股市必读：仁和药业（000650）5月18日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2636003858","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636003858?lang=zh_cn&edition=full","pubTime":"2026-05-19 01:52","pubTimestamp":1779126733,"startTime":"0","endTime":"0","summary":"截至2026年5月18日收盘，仁和药业报收于5.52元，下跌0.9%，换手率0.91%，成交量12.07万手，成交额6659.83万元。董秘最新回复投资者： 董秘你好，感谢回复。系统显示的发送成功时间是：2026年5月13日17：44。董秘： 尊敬的投资者您好，公司每个部门都有其明确的职能，证券部不是全能部门，涉及正常商业咨询或投诉，请致电公司全国统一400客服号。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900002152.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0239","BK0188","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636023320","title":"仁和药业：目前公司有减肥药品的销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2636023320","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636023320?lang=zh_cn&edition=full","pubTime":"2026-05-18 16:03","pubTimestamp":1779091391,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)05月18日在投资者关系平台上答复投资者关心的问题。投资者提问：你好！世界医药巨头礼来和诺和诺德都非常看好最新的减肥加增肌的口服药，研究和开发费用惊人！请问，贵司有没有计划开发口服的减肥加增肌的新一代减肥药物吗？谢谢！仁和药业回复：尊敬的投资者您好，目前公司有减肥药品的销售。您提到的新一代减肥药物的研发，建议收到。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800020464.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000650","BK0188","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636046561","title":"仁和药业：股东会审议通过后两个月内完成分红派息","url":"https://stock-news.laohu8.com/highlight/detail?id=2636046561","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636046561?lang=zh_cn&edition=full","pubTime":"2026-05-18 11:36","pubTimestamp":1779075370,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)05月18日在投资者关系平台上答复投资者关心的问题。投资者提问：你好。公司什么时候分红派息仁和药业回复：尊敬的投资者您好，根据工作安排，公司2025年度股东会计划于6月份召开，股东会审议通过后届时在两个月内完成分红派息工作。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800012757.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0188","000650","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635673309","title":"仁和药业（000650）披露回购公司股份比例达到1%暨回购进展的公告，5月13日股价下跌0.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635673309","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635673309?lang=zh_cn&edition=full","pubTime":"2026-05-13 22:30","pubTimestamp":1778682631,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘，仁和药业报收于5.67元，较前一交易日下跌0.35%，最新总市值为79.38亿元。该股当日开盘5.68元，最高5.72元，最低5.65元，成交额达7254.13万元，换手率为0.96%。近日，仁和药业股份有限公司发布《关于回购公司股份比例达到1%暨回购进展的公告》。公告显示，公司于2026年4月22日召开董事会，审议通过以集中竞价交易方式回购公司股份的方案，拟使用自有资金8,000万至15,000万元回购股份，用于股权激励或员工持股计划，回购价格不超过8.00元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300045766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","000650","BK0239","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635275306","title":"仁和药业：产品质量始终是品牌的立业之本","url":"https://stock-news.laohu8.com/highlight/detail?id=2635275306","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635275306?lang=zh_cn&edition=full","pubTime":"2026-05-13 11:37","pubTimestamp":1778643433,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)05月12日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！贵公司这次赞助江西足球赛事，打出了仁心仁爱，仁和药业横幅，证明公司对体育事业发展起到了积极推动作用，公司是不是打算打造百年仁和？是不是准备把品质和口碑做起来？仁和药业回复：尊敬的投资者您好，产品质量始终是品牌的立业之本，我们一直放在首位。感谢您对公司的关注和支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300017997.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650","BK0239","BK0188","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634442550","title":"股市必读：仁和药业（000650）5月8日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2634442550","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634442550?lang=zh_cn&edition=full","pubTime":"2026-05-11 01:54","pubTimestamp":1778435653,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，仁和药业报收于5.71元，上涨0.35%，换手率0.96%，成交量12.84万手，成交额7333.44万元。中药经典名方二冬汤颗粒未参与2025年医保谈判，已有销售但利润贡献有限。二冬汤颗粒为公司首个获批的经典名方产品，具体获批时间依国家药监局审评进度而定。医药OTC行业处于2025年深度调整、2026年筑底企稳的过渡期。2026年一季度公司营收同比增长14.57%，扣非净利润增长33.20%，主因药品主业利润贡献上升，从上年同期1.02亿元增至1.36亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100000913.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650","BK0239","BK0188","BK0097"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1782109674909,"stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.079},{"period":"3month","weight":-0.0936},{"period":"6month","weight":-0.1261},{"period":"1year","weight":-0.05},{"period":"ytd","weight":-0.092}],"compareEarnings":[{"period":"1week","weight":0.026},{"period":"1month","weight":-0.019},{"period":"3month","weight":0.0337},{"period":"6month","weight":0.0514},{"period":"1year","weight":0.2071},{"period":"ytd","weight":0.0306}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"仁和药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"89600人(较上一季度减少0.67%)","perCapita":"14859股","listingDate":"1996-12-10","address":"江西省宜春市樟树市葛玄路6号","registeredCapital":"139993万元","survey":" 仁和药业股份有限公司的主营业务是药品及大健康产品的生产和销售。公司的主要产品是口服固体制剂、口服液体制剂、大容量注射剂、小容量注射剂、外用洗剂、搽剂、栓剂、软膏剂、健康相关产品。","listedPrice":6.26},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"仁和药业(000650)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供仁和药业(000650)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"仁和药业,000650,仁和药业股票,仁和药业股票老虎,仁和药业股票老虎国际,仁和药业行情,仁和药业股票行情,仁和药业股价,仁和药业股市,仁和药业股票价格,仁和药业股票交易,仁和药业股票购买,仁和药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"仁和药业(000650)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供仁和药业(000650)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}